FDA to use AI in drug approvals to ‘radically increase efficiency’

The Food and Drug Administration is planning to use artificial intelligence to “radically increase efficiency” in deciding whether to approve new drugs and devices, one of several top priorities laid out in an article published today in JAMA.

See the original article at: Honolulu Star-Advertiser

<--- Like this post? You know what to do.

Comments are closed.